CAS 864814-88-0 appears in our catalog under these names: Resminostat, 98+%, Resminostat, Resminostat (RAS2410), Resminostat, 99.84%, Resminostat, 98%. Offered by: AmBeed, TargetMol, GLPBio, Biosynth, Chemat. Available pack sizes: 1g, 250mg, 5mg, 10mg, 25mg, 50mg, 100 mg, 25 mg.
Resminostat is an enamide resulting from the formal condensation of the carboxy group of (2E)-3-[1-({4-[(dimethylamino)methyl]phenyl}sulfonyl)-1H-pyrrol-3-yl]prop-2-enoic acid with the amino group of hydroxylamine. It is an orally bioavailable inhibitor of histone deacetylases with potential antineoplastic activity. It has a role as an antineoplastic agent, an EC 3.5.1.98 (histone deacetylase) inhibitor and an apoptosis inducer. It is a member of benzenes, a hydroxamic acid, a member of pyrroles, a sulfonamide, a tertiary amino compound and an enamide.
Source: ChEBI
| Molecular formula | C16H19N3O4S |
|---|---|
| Molecular weight | 349.4 g/mol |
| IUPAC name | (E)-3-[1-[4-[(dimethylamino)methyl]phenyl]sulfonylpyrrol-3-yl]-N-hydroxyprop-2-enamide |
| InChIKey | FECGNJPYVFEKOD-VMPITWQZSA-N |
| SMILES | CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)/C=C/C(=O)NO |
Computed by PubChem (NCBI)